Health Condition 1: J019- Acute sinusitis, unspecified Health Condition 2: L239- Allergic contact dermatitis, unspecified cause Health Condition 3: J300- Vasomotor rhinitis
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients of age between 18 to 65 years. 2.Patients having symptoms of allergic rhinitis, sinusitis and skin allergy. 3.Scores from the global scale atopic dermatitis vIGA 4.Patients willing to comply by the study procedures and sign an informed consent form.
Exclusion criteria
Exclusion criteria: 1.Patients with poorly controlled Hypertension or with uncontrolled Diabetes Mellitus and having a past history of Atrial Fibrillation, Acute Coronary Syndrome, Myocardial Infarction, Stroke or Severe Arrhythmia in the last 6 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary Endpoint: 1.Reduced symptoms of Sinusitis and Rhinitis (Fever if present is significantly improving, nasal discharge is lessening and reduced fatigue) 2.Assess the improvement in Skin Allergy Timepoint: 1.Day 1,15,30,45 and 60 | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Assessment of adverse events during the treatment phase (percentage & treatment discontinuation rates due to AEs will be assessed)Timepoint: Day 15,30,45,60 | — |
Countries
India
Contacts
LIFE AVEDA